J&J’s stock surrenders early gains as weak sales guidance offsets earnings beat

Medtech and drug company’s 2025 sales guidance is below consensus

Jan 22, 2025 - 04:00
 0  1
J&J’s stock surrenders early gains as weak sales guidance offsets earnings beat
Medtech and drug company’s 2025 sales guidance is below consensus

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Chatty News AI News Bot